MXPA03002957A - Uso de bacteria probiotica de acido lactico para balancear el sistema inmune de la piel. - Google Patents

Uso de bacteria probiotica de acido lactico para balancear el sistema inmune de la piel.

Info

Publication number
MXPA03002957A
MXPA03002957A MXPA03002957A MXPA03002957A MXPA03002957A MX PA03002957 A MXPA03002957 A MX PA03002957A MX PA03002957 A MXPA03002957 A MX PA03002957A MX PA03002957 A MXPA03002957 A MX PA03002957A MX PA03002957 A MXPA03002957 A MX PA03002957A
Authority
MX
Mexico
Prior art keywords
skin
balancing
lactic acid
immune system
acid bacteria
Prior art date
Application number
MXPA03002957A
Other languages
English (en)
Inventor
Audrey Gueniche
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MXPA03002957A publication Critical patent/MXPA03002957A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

La presente invencion pertenece al uso de probioticos para la preparacion de un portador para balancear la funcion inmune de la piel. En particular, la presente invencion pertenece al uso de microorganismos probioticos para balancear la funcion inmune de la piel bajo condiciones de estres, tal como una exposicion a radiacion ultravioleta, especificamente para aumentar la actividad inmune de la piel y reducir la tendencia a desarrollar reacciones alergicas bajo tales condiciones.
MXPA03002957A 2000-10-06 2001-10-04 Uso de bacteria probiotica de acido lactico para balancear el sistema inmune de la piel. MXPA03002957A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00121865 2000-10-06
PCT/EP2001/011475 WO2002028402A1 (en) 2000-10-06 2001-10-04 Use of probiotic lactic acid bacteria for balancing the skin's immune system

Publications (1)

Publication Number Publication Date
MXPA03002957A true MXPA03002957A (es) 2005-06-30

Family

ID=8170032

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002957A MXPA03002957A (es) 2000-10-06 2001-10-04 Uso de bacteria probiotica de acido lactico para balancear el sistema inmune de la piel.

Country Status (14)

Country Link
US (2) US7547527B2 (es)
EP (2) EP1593382A1 (es)
JP (1) JP4510376B2 (es)
CN (1) CN100553646C (es)
AR (1) AR033580A1 (es)
AT (1) ATE490776T1 (es)
AU (2) AU2002220587B2 (es)
BR (1) BRPI0114400B8 (es)
CA (1) CA2424607C (es)
DE (1) DE60143616D1 (es)
ES (1) ES2357419T3 (es)
MX (1) MXPA03002957A (es)
PT (1) PT1322318E (es)
WO (1) WO2002028402A1 (es)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60305159T2 (de) * 2002-02-21 2007-03-15 Société des Produits Nestlé S.A. Oral verabreichbare zusammensetzung zum schutz der haut vor licht
FR2844198A1 (fr) * 2002-09-06 2004-03-12 Oreal Utilisation d'un activeur de protectin pour ameliorer la resistance de la peau, composition contenant de tels activateurs et procede de selection
US20050180962A1 (en) * 2003-01-30 2005-08-18 Eyal Raz Inactivated probiotic bacteria and methods of use thereof
KR100908254B1 (ko) * 2003-03-13 2009-07-20 기린 홀딩스 가부시키가이샤 항알레르기용 조성물
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
AU2005257033B2 (en) 2004-06-23 2011-05-12 L'oreal Method and compositions useful for preventing and/or treating sensitive and/or dry skin
BRPI0516437A (pt) * 2004-10-04 2008-09-02 Oreal E Nestec S A L utilização de uma quantidade eficaz de pelo menos um microorganismo, processo de tratamento cosmético, composição cosmética e/ou dermatológica e composição para absorção oral
EP1683425A1 (en) * 2005-01-21 2006-07-26 Compagnie Gervais Danone Use of a fermented milk containing L. Casei for the manufacture of a composition for the prevention or treatment of a delayed-type hypersensitivity reaction
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
BRPI0611493B1 (pt) 2005-05-31 2022-04-05 Alimentary Health Ltd. Lactobacilos probióticos felinos
EP1736537A1 (en) * 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
EA013926B1 (ru) * 2005-06-24 2010-08-30 Калпис Ко., Лтд. Промотор дифференциации и кератинизации эпидермальной клетки и функциональный напиток/питание для ускорения кератинизации эпидермиса
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
WO2007046441A1 (ja) 2005-10-18 2007-04-26 Kao Corporation ペットフード
WO2008078387A1 (ja) 2006-12-26 2008-07-03 Meiji Dairies Corporation 皮膚改善用及び／又は治療用の発酵乳とその製造方法
CA2673465A1 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal
FR2912917B1 (fr) * 2007-02-26 2012-05-18 Oreal Milieu conditionne et ses utilisations
FR2912916B1 (fr) * 2007-02-26 2009-05-22 Oreal Composition cosmetique ou dermatologique comprenant un milieu de culture cellulaire
WO2008120713A1 (ja) * 2007-03-30 2008-10-09 Suntory Holdings Limited 副交感神経活動亢進作用を有する医薬組成物又は飲食物
JP2009102292A (ja) * 2007-04-27 2009-05-14 Chiba Prefecture ストレス抑制剤
FR2919501B1 (fr) * 2007-08-02 2010-12-31 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920300B1 (fr) * 2007-09-04 2012-12-28 Oreal Utilisation d'une association hesperidine et microorganisme pour agir sur la fonction barriere de la peau.
FR2920307B1 (fr) * 2007-09-04 2010-06-04 Oreal Utilisation cosmetique de microorganismes.
ES2461791T3 (es) * 2007-09-04 2014-05-21 L'oréal Utilización de una combinación de hesperidina y de un microorganismo para actuar sobre la función de barrera de la piel
FR2920304B1 (fr) * 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
FR2938429B1 (fr) * 2008-11-19 2012-05-18 Oreal Utilisation cosmetique de microorganisme(s) pour le traitement des desordres du cuir chevelu
BRPI0916690B1 (pt) * 2008-07-29 2022-04-12 L'oreal Uso de uma quantidade eficaz de pelo menos um microorganismo probiótico, composição coméstica e/ou dermatólogica, método coméstico para tratar e/ou prevenir distúrbios estéticos do couro cabeludo em um indivíduo, processo cosmético para prevenir e/ou tratar uma condição de caspa do couro cabeludo, conjunto cosmético, e, uso cosmético de pelo menos uma quantidade eficaz de pelo menos um primeiro e um segundo agente cosmético ativo
FR2938437B1 (fr) 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
FR2945944B1 (fr) * 2009-06-02 2011-07-15 Oreal Procede cosmetique de traitement des etats pelliculaires comprenant l'administration d'un microorganisme probiotique et d'un actif antipelliculaire
FR2937547B1 (fr) 2008-10-28 2012-11-09 Oreal Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses
FR2937536B1 (fr) * 2008-10-28 2016-07-01 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement du cuir chevelu gras
FR2940908B1 (fr) * 2009-01-12 2012-08-24 Oreal Association cosmetique d'un microorganisme et d'un derive phytosphingosine
FR2942720B1 (fr) * 2009-03-03 2024-01-19 Oreal Utilisation cosmetique d'hesperidine.
FR2942719B1 (fr) * 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
BRPI1014304A2 (pt) * 2009-05-11 2016-04-05 Nestec Sa bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
US20110027417A1 (en) * 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
US9210945B2 (en) * 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US9173423B2 (en) 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
FR2951377B1 (fr) * 2009-10-21 2012-06-22 Oreal Association d'un lysat de probiotique et d'un derive c-glycoside
FR2953408B1 (fr) * 2009-12-08 2013-02-08 Oreal Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau
FR2953407B1 (fr) * 2009-12-08 2013-06-14 Oreal Microorganismes probiotiques a titre d'actif contre les alterations du microrelief
BR112012016676A2 (pt) * 2010-01-06 2018-06-05 Kabushiki Kaisha Yakult Honsa promotor de reparo do dano ao dna para a aplicação oral e inibidor da atividade de elastase para a aplicação oral.
FR2959128B1 (fr) 2010-04-23 2012-07-13 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement des odeurs corporelles
EP2397145A1 (en) * 2010-06-18 2011-12-21 Nestec S.A. L. johnsonii La1, B. longum NCC2705 and immune disorders
JP2010280664A (ja) * 2010-07-02 2010-12-16 Biogaia Ab ラクトバチルス・リューテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ）株を用いる哺乳類における免疫機能の改善方法
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
CN102335413B (zh) * 2011-08-16 2014-07-09 东北农业大学 一种具抗β-乳球蛋白过敏效果的乳杆菌完整肽聚糖的制备方法、产品及其应用
CN102578416B (zh) * 2012-02-23 2014-06-18 北京大北农科技集团股份有限公司 约氏乳杆菌在制备提高畜禽免疫水平饲料中的应用
MX2015001751A (es) 2012-08-07 2015-11-13 Topgenix Inc Composicion topica comprendiendo bacterias transformadas que expresan un compuesto de interes.
FR2999601B1 (fr) 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
FR2999931A1 (fr) 2012-12-21 2014-06-27 Oreal Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2999932B1 (fr) 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
KR20170019427A (ko) 2014-06-17 2017-02-21 탑제닉스, 인크. Ｕｖ 차단을 위한 국소용 제형
US9913799B2 (en) 2014-07-11 2018-03-13 Mary Kay Inc. Cosmetic compositions and methods of their use
CN107635408B (zh) 2015-02-16 2021-05-25 马斯公司 连锁的粗磨物
MX2017013715A (es) 2015-04-28 2018-03-02 Mars Inc Proceso de preparacion de un producto de alimento para mascotas humedo esterilizado.
LT6463B (lt) 2015-12-10 2017-10-10 Uab "Probiosanus" Probiotinių bakterijų (pb) gyvybingumo ir stabilumo padidinimas detergentų turinčiuose asmens higienos ir buities priežiūros produktuose
WO2017109623A1 (en) * 2015-12-22 2017-06-29 Nestec Sa Immune health for companion animals
AU2017240069B2 (en) 2016-03-31 2024-03-07 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US10258567B1 (en) 2016-11-17 2019-04-16 Grace Procurements Llc Vaginal probiotic products and related processes
CN106727263B (zh) * 2016-11-22 2019-10-25 深圳弘睿康生物科技有限公司 皮肤微生态改善制剂及其制备方法
CA3043748A1 (en) 2016-11-23 2018-05-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
EP3585356A4 (en) * 2017-02-27 2020-11-04 Continuum Group LLC SUN SCREEN
US20200376047A1 (en) * 2017-04-11 2020-12-03 Servatus Ltd Methods for the treatment of inflammation and inflammatory conditions
US11229806B2 (en) * 2017-05-08 2022-01-25 L'oreal Cold atmospheric plasma treatment with chemical or organic compounds to modify the keratinous substrate microbiota
CN111511379B (zh) 2017-12-06 2024-06-18 Lac2生物群系有限公司 基于益生菌的组合物及其应用
CA3090042A1 (en) * 2018-02-02 2019-08-08 Postbiotica S.R.L. Use of a postbiotic-based composition for the treatment of skin diseases
KR102011240B1 (ko) * 2019-01-31 2019-08-14 에스케이바이오랜드 주식회사 신규한 락토바실러스 파라카제이 skb1192 균주 또는 이를 함유하는 광보호 효능이 있는 조성물 및 그 제품
CN110973254B (zh) * 2019-12-20 2023-03-14 光明乳业股份有限公司 一种可常温存放的活菌酸奶及其制备方法
KR102558085B1 (ko) * 2021-09-08 2023-07-24 코스맥스 주식회사 비피도박테리움 애니멀리스 서브스페시스 락티스 균주 및 그의 피부 상태 개선 용도

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244691B (it) * 1991-01-29 1994-08-08 Sitia Yomo Spa Mousse lattea, suo impiego per preparare dessert e dessert cosi' ottenuti
JPH0517363A (ja) * 1991-07-11 1993-01-26 Yakult Honsha Co Ltd 抗炎症剤及びそれを含有する化粧料
KR950014592B1 (ko) * 1991-10-22 1995-12-11 주식회사태평양 화장료용 유산균제재
ATE172245T1 (de) * 1992-07-06 1998-10-15 Nestle Sa Milchbakterien
US5302389A (en) 1992-08-17 1994-04-12 Board Of Regents, The University Of Texas System Method for treating UV-induced suppression of contact hypersensitivity by administration of T4 endonuclease
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
FR2705015B1 (fr) * 1993-05-10 1995-08-04 Agronomique Inst Nat Rech Produits du type fromages frais et leur procédé d'obtention.
JPH07194317A (ja) * 1993-12-29 1995-08-01 Nichinichi Seiyaku Kk ペットフード
FR2718752B1 (fr) * 1994-04-15 1996-07-12 World Trust Investment Sa Préparations à base de lactosérum fermenté et leurs utilisations.
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JP3995733B2 (ja) * 1995-07-17 2007-10-24 明治乳業株式会社 免疫賦活組成物
JPH09263539A (ja) * 1996-03-29 1997-10-07 Nichinichi Seiyaku Kk 抗真菌作用を有する皮膚疾患治療剤
JPH09301878A (ja) * 1996-05-13 1997-11-25 Youshindou:Kk 腫瘍増殖抑制剤
FR2750298B1 (fr) * 1996-07-01 1998-09-18 Gefa Composition en poudre pour la preparation d'un aliment a base de yaourt
ES2167719T3 (es) * 1996-09-10 2002-05-16 Nestle Sa Alimento deshidratado que contiene bacterias de acido lactico.
JP4064481B2 (ja) * 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 免疫賦活剤
JPH10139674A (ja) * 1996-11-11 1998-05-26 Yakult Honsha Co Ltd インターロイキン１２産生促進剤
IL130285A0 (en) 1996-12-24 2000-06-01 Nestle Sa Fermented dairy product
DK0862863T4 (da) * 1997-01-09 2008-12-01 Nestle Sa Kornprodukt indeholdende probiotika
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
WO1999017788A1 (en) * 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
US5902743A (en) * 1998-03-20 1999-05-11 Wisconsin Alumni Research Foundation Probiotic bifidobacterium strain
JP2000095697A (ja) * 1998-09-18 2000-04-04 Advance Co Ltd 抗アレルギー剤
ID30071A (id) 1998-12-11 2001-11-01 Urex Biotech Inc Pemberian oral lactobacillus untuk pengobatan dan pencegahan infeksi urogental
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
DE19909820A1 (de) * 1999-02-22 2000-08-24 Heinz Nuenninghoff Kit zur Zubereitung eines Milch- oder Milchmischproduktes und Milch- oder Milchmischprodukt
FR2789854B1 (fr) * 1999-02-23 2001-05-25 Le Sojami Soc Procede de fabrication d'une preparation glacee a base de laits vegetaux, notamment de soja et produits obtenus
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
JP4388644B2 (ja) * 1999-10-18 2009-12-24 大洋香料株式会社 新規乳酸菌発酵代謝物を含有する化粧料
DE10021384A1 (de) * 2000-05-03 2001-11-15 Hora Reiner Ergänzungsfutter für Haustiere
JP2002037739A (ja) * 2000-07-24 2002-02-06 Mikimoto Pharmaceut Co Ltd 免疫調整剤

Also Published As

Publication number Publication date
ATE490776T1 (de) 2010-12-15
US20100080782A1 (en) 2010-04-01
BR0114400A (pt) 2003-08-26
JP2004510740A (ja) 2004-04-08
PT1322318E (pt) 2011-03-15
EP1322318A1 (en) 2003-07-02
AU2002220587B2 (en) 2006-06-29
US7547527B2 (en) 2009-06-16
AU2058702A (en) 2002-04-15
JP4510376B2 (ja) 2010-07-21
CA2424607C (en) 2013-01-15
BRPI0114400B8 (pt) 2021-05-25
US20040013706A1 (en) 2004-01-22
WO2002028402A1 (en) 2002-04-11
EP1593382A1 (en) 2005-11-09
CN100553646C (zh) 2009-10-28
AR033580A1 (es) 2003-12-26
BR0114400B1 (pt) 2014-04-01
EP1322318B1 (en) 2010-12-08
ES2357419T3 (es) 2011-04-26
DE60143616D1 (de) 2011-01-20
CA2424607A1 (en) 2002-04-11
US8377679B2 (en) 2013-02-19
CN1468105A (zh) 2004-01-14

Similar Documents

Publication Publication Date Title
MXPA03002957A (es) Uso de bacteria probiotica de acido lactico para balancear el sistema inmune de la piel.
MY127895A (en) New lactic acid bacteria strains capable of preventing diarrhoea
GR3033850T3 (en) Chloropyrimide intermediates
GR3026758T3 (en) Lactobacillus strains of human origin, their compositions and uses thereof
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
MXPA02000119A (es) Elementos mezcladores estaticos apilados.
HK1079104A1 (en) Orally administrable composition to human for the photoprotection of the skin
MY124559A (en) Anti-stress agent and functional food having anti-stress effect
WO2001052667A3 (en) Pet food composition for treating helicobacter species in pets
MXPA03001673A (es) Bacteria de acido lactico capaz de reducir una tendencia individual a desarrollar reacciones alergicas.
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
TR200200301T2 (tr) Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler
MXPA04005346A (es) Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino.
TW200637542A (en) Lipase inhibitor, preventing and treating agent of skin disease
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
CA2294670A1 (en) Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora
EP1541672A4 (en) COMPOSITION FOR PROLIFERATING LACTOBACILLUS CASEI SUBSP. CASEI
RS20050130A (en) The use of fermented wheat-germ in the feeding and veterinary practice
IT1294368B1 (it) Microorganismi inattivati contenenti enzimi digestivi, processo per la loro preparazione e loro uso in campo alimentare
ATE285757T1 (de) Inaktivierte mikroorganismen, die pharmakologisch aktive substanzen enthalten
ATE291353T1 (de) Verwendung von milchsaürebakterien bei der herstellung von fermentierten milchprodukten zur behandlung von verringerten immunitätsebenen
RU98112855A (ru) Штамм бактерий bifidobacterium longum z4 для приготовления бактерийных препаратов, нормализующих микрофлору при нарушениях микробиоценоза влагалища
RU2002118758A (ru) Штамм энтерококков Enterococcus faecium L-3 для изготовления лечебно-профилактических средств и продуктов питания лечебно-профилактического назначения
EP1402886A4 (en) LIPOLYSIS ACCELERATOR, DERMATOLOGICAL COSMETIC PREPARATION FOR REDUCING BODY MASS, AND FOOD OR BEVERAGE COMPOSITION CONTAINING THE ACCELERATOR, AND METHOD FOR REDUCING BODY MASS AND MEDICINAL USE BASED ON THE ACTIVITY OF THE ACCELERATOR
UA34283A (uk) Спосіб діагностики порушень імунологічного статусу у людини та тварин

Legal Events

Date Code Title Description
FG Grant or registration